Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Forum: Aktien User: Coronaprofiteur

Weiß jemand eine plausible Begründung für den Rücksetzer?

Hab meine Position noch mit 22 % Profit erstmal geschlossen, durch die Klage Zeit Novo eine sehr schwache Reaktion.

Luft ist wieder raus.

Betrifft das Novo?

$NVO $LLY Dr. Reddy's says its semaglutide supply disruption could now affect availability beyond India and Canada as the company pursues launches in Brazil, Turkey, and Mexico. The company said production will likely take another three to four months to scale back up after an impurity issue forced it to halt new batches. As a result, it has cut its FY2027 semaglutide sales target from 12 million pens to 6 to 7 million pens. Dr. Reddy's said regulatory filings in new markets remain on track, but limited production means supply will need to be allocated once manufacturing resumes. Link to article: reuters.com/business/healt… #stocks #Investing

$NVO $LLY Reuters spoke with doctors and analysts about the first weeks of the new U.S. Medicare obesity drug pilot, and one early trend stands out. Although many expected patients to prefer pills for convenience, most doctors interviewed said patients are choosing injectable treatments such as Novo's Wegovy and Lilly's Zepbound instead. Several analysts also said efficacy appears to matter more than convenience for most patients. Reuters notes that Novo Nordisk had previously said its research suggested Medicare beneficiaries preferred an oral treatment over an injection by roughly two to one. However, physicians say many patients are specifically requesting injections because they know they deliver greater weight loss. Doctors also reported that the rollout has generally gone well. CMS said most coverage authorizations are being completed in less than 12 hours, while some clinics have already received approvals for hundreds of eligible patients. However, physicians also described the process as administratively burdensome, with significant paperwork required to secure patient access.